DETECT" Advances in the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician

Target Audience
This activity is designed to meet the educational needs of Pediatric Endocrinologists, Adult Endocrinologists, Pediatricians, Primary Care Providers (PCPs), and Endocrine Nurses.

Program Overview
This educational program focuses on the early screening, detection, and advances in the treatment of early-stage type 1 diabetes (T1D). Through this enduring Grand Rounds session, clinicians will be able to review the importance and benefits of early screening, how to screen & stage T1D, as well as the latest evidence with disease-modifying therapies for early stage T1D. This program will also outline appropriate and practical strategies on how to apply monitoring and early screening for individuals at high risk, along with considerations for treatment in this setting.

Learning Objectives
Upon completion of this activity, participants should be able to:

Describe the clinical presentation of T1D in adults compared to children
Identify appropriate autoantibody screening strategies for T1D, including type, frequency, and number
Interpret results from screening protocols to drive management decisions
Discuss the latest clinical evidence for efficacy and tolerability of newly approved and investigational immunomodulatory agents
Implement strategies for appropriate clinical monitoring and early screening in individuals at highest risk